|
|
|
Volumn 25, Issue 6, 2011, Pages 383-
|
|
Early end for FEM-PrEP HIV prevention trial.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
TENOFOVIR;
DRUG COMBINATION;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KENYA;
NOTE;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SOUTH AFRICA;
TANZANIA;
ADENINE;
ADMINISTRATION, ORAL;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DRUG COMBINATIONS;
FEMALE;
HIV INFECTIONS;
HUMANS;
KENYA;
ORGANOPHOSPHORUS COMPOUNDS;
PATIENT COMPLIANCE;
PHOSPHONIC ACIDS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SOUTH AFRICA;
TANZANIA;
|
|
EID: 79961110765
PISSN: None
EISSN: 15577449
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|